3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Frailty
3
Neoplasms
2
Stomach Neoplasms
1
Recurrence
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Myeloid, Acute
1
Dendritic Cell Sarcoma, Interdigitating
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Rituximab
57
Cyclophosphamide
40
Vincristine
26
Prednisone
25
Doxorubicin
22
Cytarabine
18
Lenalidomide
17
Etoposide
17
Gemcitabine
12
Melphalan
8
Filgrastim
8
Cisplatin
8
zanubrutinib
7
Peripheral Blood Stem Cell Transplantation
7
Oxaliplatin
7
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
7
Methotrexate
7
Ifosfamide
7
Carmustine
7
R-CHOP protocol
6
fludarabine phosphate
5
Vindesine
5
Radiotherapy
5
Dexamethasone
5
Decitabine
5
Busulfan
5
ibrutinib
4
Methylprednisolone
4
Epirubicin
4
Cyclosporine
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Lymphoma, Large B-Cell, Diffuse
×
Geriatric Assessment
×
Clear all
NCT04113226
2023-02-08
Relyage
Centre Hospitalier Universitaire, Amiens
Phase 2
Unknown
114 enrolled